Back
ClearPoint Neuro 10K Form
Sell
20
CLPT
ClearPoint Neuro
Last Price:
5.29
Seasonality Move:
-9.27%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CLPT News And Ratings
See the #1 stock for the next 7 days that we like better than CLPT
CLPT Financial Statistics
Sales & Book Value
| Annual Sales: | $23.96M |
|---|---|
| Cash Flow: | $-1.36M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.86 |
| Price / Book: | 6.7 |
Profitability
| EPS (TTM): | -0.91000 |
|---|---|
| Net Income (TTM): | $-22.09M |
| Gross Margin: | $13.61M |
| Return on Equity: | -77.7% |
| Return on Assets: | -46.04% |
ClearPoint Neuro Earnings Forecast
Key ClearPoint Neuro Financial Ratios
- The Gross Profit Margin over the past 14 years for CLPT is 56.83%.
- The Selling, General & Administrative Expenses for CLPT have been equal to 101.65% of Gross Profit Margin.
- The Research & Development expenses have been 48.88% of Revenue.
- The Interest Expense is -0.49% of Operating Income.
- The Net Earning history of CLPT is -92.21% of Total Revenues.
- Per Share Earnings over the last 14 years have been positive in 9 years.
ClearPoint Neuro Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | CLPT |
| CUSIP: | 18507C |
| Website: | clearpointneuro.com |
Debt
| Debt-to-Equity Ratio: | 0.47 |
|---|---|
| Current Ratio: | 4.87 |
| Quick Ratio: | 3.55 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CLPT Technical Analysis vs Fundamental Analysis
Sell
20
ClearPoint Neuro (CLPT)
is a Sell
Is ClearPoint Neuro a Buy or a Sell?
-
ClearPoint Neuro stock is rated a Sell
The current ClearPoint Neuro [CLPT] share price is $5.26. The Score for CLPT is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.